Brief description of trial (Data source: BASEC)
Diese Studie wird als randomisierte kontrollierte Pilotstudie durchgeführt, dies bedeutet, dass alle Teilnehmenden per Zufall einer Gruppe zur Durchführung des Trainings unter Blutflussreduktion oder einer Gruppe zur Durchführung des traditionellen Krafttrainings zugeteilt werden. Alle Teilnehmenden bleiben für 12 Wochen (die Dauer des ambulanten pulmonalen Rehabilitationsprogramms) in der Studie. Es werden insgesamt 30 Personen zur Teilnahme an dieser Studie eingeschlossen.
Health conditions investigated(Data source: BASEC)
Chronisch obstruktive Lungenerkrankung (COPD)
Health conditions
(Data source: WHO)
COPD;Muscle Weakness
Rare disease
(Data source: BASEC)
No
Intervention investigated (e.g. drug, therapy or campaign)
(Data source: BASEC)
Krafttraining mit geringem Gewicht unter Blutflussreduktion (low-load blood flow restriction training)
Interventions
(Data source: WHO)
Other: Low-load blood flow restriction training;Other: Usual outpatient pulmonary rehabilitation
Criteria for participation in trial
(Data source: BASEC)
diagnostizierte COPD (unabhängig vom Schweregrad), Zuweisung zur ambulanten pulmonalen Rehabilitation am Universitätsspital Zürich, mindestens 40 Jahre alt
Exclusion criteria
(Data source: BASEC)
pulmonale Rehabilitation in den letzten 3 Monaten, Exazerbation der COPD in den letzten 6 Wochen, Thrombose oder Polyneuropathie in den Beinen
Inclusion/Exclusion Criteria
(Data source: WHO)
Gender: All
Maximum age: N/A
Minimum age: 40 Years
Inclusion Criteria:
- Diagnosed COPD according to GOLD-guidelines
- Assigned to outpatient pulmonary rehabilitation by the treating physician
Exclusion Criteria:
- Physical or intellectual impairment precluding informed consent or protocol adherence
- Non-German speaking (precluding informed consent)
- Acute or recent (within the last 6 weeks) exacerbation of COPD
- Attending a pulmonary rehabilitation program within the last 3 months
- Pregnant patients
- History of thromboembolic event in the lower extremity
- Diagnosis of polyneuropathy
- Resting systolic blood pressure <100 mmHg
-
Further information on trial
Date trial registered
Oct 31, 2019
Recruitment status
Completed
Academic title
(Data source: WHO)
Low-load Blood Flow Restriction Training in COPD
Type of trial
(Data source: WHO)
Interventional
Design of the trial
(Data source: WHO)
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Phase
(Data source: WHO)
N/A
Primary end point
(Data source: WHO)
Knee extensor strength
Contact information
(Data source: WHO)
Please refer to primary and secondary sponsors
Trial results
(Data source: WHO)
Results summary
no information available yet
Link to the results in the primary register
no information available yet
Information on the availability of individual participant data
no information available yet
Trial sites
Trial sites in Switzerland
(Data source: BASEC)
Zurich
Countries
(Data source: WHO)
Switzerland
Contact for further information on the trial
Details of contact in Switzerland
(Data source: BASEC)
PD Dr. med. Christian Clarenbach
+41 44 255 17 12
christian.clarenbach@usz.ch
Contact for general information
(Data source: WHO)
Christian F Clarenbach, MD
+41 44 255 17 12
christian.clarenbach@usz.ch
Contact for scientific information
(Data source: WHO)
Christian F Clarenbach, MD
+41 44 255 17 12
christian.clarenbach@usz.ch
Authorisation by the ethics committee (Data source: BASEC)
Name of the authorising ethics committee (for multicentre studies only the lead committee)
Kantonale
Ethikkommission Zürich
Date of authorisation by the ethics committee
28.10.2019
Further trial identification numbers
Trial identification number of the ethics committee (BASEC-ID)
(Data source: BASEC)
2019-01641
Secondary ID (Data source: WHO)
SNCTP000003509
Back to overview
